The landscape of metabolic management is rapidly evolving , with the emergence of dual GIP and GLP-1 receptor agonists. Both Tirzepatide and Retatrutide represent important advancements; Tirzepatid already https://vinnygzkd649836.blogpixi.com/43280804/tirzepatide-this-retatrutide-a-emerging-weight-management-duo